Top Markets
Coin of the day
Achilles Therapeutics plc Achilles Therapeutics plc

Achilles Therapeutics plc

ACHL
Classifica tra le azioni #24579
Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused... Achilles Therapeutics Plc is a clinical-stage biopharmaceutical company focused on immuno-oncology. The firm specializes in creating innovative precision T-cell therapies designed to combat a range of solid tumors. Its primary therapeutic candidates, both currently undergoing Phase I/IIa clinical trials, are CHIRON, aimed at advanced non-small cell lung cancer, and THETIS, targeting metastatic or recurrent melanoma. Beyond these, Achilles is also advancing its pipeline with treatments for head and neck squamous cell carcinoma, renal cell carcinoma, triple-negative breast cancer, and bladder cancer. Initially incorporated as Achilles TX Limited, the company officially adopted the name Achilles Therapeutics Plc in February 2021. Established in 2016, its corporate headquarters are situated in London, United Kingdom.
Prezzo delle azioni
$1.48
Ultima sincronizzazione: 2025-03-24
Capitalizzazione di mercato
$59.05M
Variazione (1 giorno)
0.00%
Variazione (1 anno)
0.00%
Paese
GB
Scambia Achilles Therapeutics plc (ACHL)

Categoria

Storico del prezzo dell'azione per Achilles Therapeutics plc (ACHL)
Prezzo di chiusura più alto: $1.42 il 2025-03-01

Prezzo di chiusura più basso: $16.55 il 2021-03-01
Storico del prezzo dell'azione di Achilles Therapeutics plc dal 2021 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2025 35.96%
2024 21.05%
2023 -23.13%
2022 -77.06%
2021 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
$547.38 37.72%
US
$1.05K 58.85%
NL
$118.70 -18.24%
AU
$140.47 435.74%
US
$770.19 9.84%
CH